Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-Pen vs Lilly Glucagon in Healthy Volunteers
NCT01972152Phase 2Completed
- Sponsor
- Xeris Biopharma Holdings, Inc.
- Start
- Oct 2013
- Primary completion
- Feb 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of G-Pen in hypoglycemia, sponsored by Xeris Biopharma Holdings, Inc.. Started Oct 2013; status: completed.
02
Drugs
G-Pen
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT01972152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01972152.